Helicobacter pylori participates in the pathogenesis of IgA nephropathy

Renal Failure

Volumn 38, Issue 9, 2016, Pages 1398-1404

  Zhu, Ting Ting ^a,b   Wang, Li ^a   Wang, Hong Lian ^a   He, Yu ^a,b   Ma, Xin ^a,b   Fan, Jun Ming ^a,b,c  

^a SOUTHWEST MEDICAL UNIVERSITY   (China)

^b THE AFFILIATED HOSPITAL OF SOUTHWEST MEDICAL UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

Helicobacter pylori infection; Hp antigen; IgA nephropathy; mucosal immune; pathogenesis

Indexed keywords

BACTERIAL ANTIGEN; CAGA PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A1; BACTERIUM ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULONEPHRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY DISEASE; KIDNEY TUBULE; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; NON IGA NEPHROPATHY; PRIORITY JOURNAL; PROGNOSIS; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN GLYCOSYLATION; RISK FACTOR; SEROLOGY; BIOPSY; COMPLICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GLOMERULONEPHRITIS, IGA; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY;

ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BIOPSY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULONEPHRITIS, IGA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN A; IMMUNOHISTOCHEMISTRY; KIDNEY TUBULES; MALE; MIDDLE AGED;

EID: 84992108837     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/0886022X.2016.1216713     Document Type: Article

References (24)

1. R.J.Wyatt, B.A.Julian IgA nephropathy. N Engl J Med. 2013;368:2402–2414.
2. K.Kiryluk, J.Novak The genetics and immunobiology of IgA nephropathy. J Clin Invest. 2014;124:2325–2332.
3. J.K.Boyd, C.K.Cheung, K.Molyneux,. An update on the pathogenesis and treatment of IgA nephropathy. Kidney Int. 2012;81:833–843.
4. H.H.Yu, K.H.Chu, Y.H.Yang,. Genetics and immunopathogenesis of IgA nephropathy. Clin Rev Allergy Immunol. 2011;41:198–213.
5. L.Engstrand, M.Lindberg Helicobacter pylori and the gastric microbiota. Best Pract Res Clin Gastroenterol. 2013;27:39–45.
6. A.Kandulski, M.Selgrad, P.Malfertheiner. Helicobacter pylori infection:A clinical overview. Dig Liver Dis. 2008;40:619–626.
7. German Campuzano-Maya. Hematologic manifestations of Helicobacter pylori infection. World J Gastroenterol. 2014;20:12818–12838.
8. H.Moyaert, F.Franceschi, D.Roccarina,. Extragastric manifestations of Helicobacter pylori infection:Other Helicobacters. Helicobacter. 2008;13:47–57.
9. H.Suzuki, F.Franceschi, T.Nishizawa,. Extragastric manifestations of Helicobacter pylori infection. Helicobacter. 2011;16:65–69.
10. J.Barratt, E.M.Bailey, K.S.Buck,. Exaggerated systemic antibody response to mucosal Helicobacter pylori infection in IgA nephropathy. Am J Kidney Dis. 1999;33:1049–1057.
11. K.Kusano, O.Tokunaga, T.Ando,. Helicobacter pylori in the palatine tonsils of patients with IgA nephropathy compared with those of patients with recurrent pharyngotonsillitis. Hum Pathol. 2007;38:1788–1797.
12. K.Kusano, A.Inokuchi, K.Fujimoto,. Coccoid Helicobacter pylori exists in the palatine tonsils of patients with IgA nephropathy. J Gastroenterol. 2010;45:406–412.
13. M.Yang, F.G.Li, X.S.Xie,. CagA, a major virulence factor of Helicobacter pylori, promotes the production and underglycosylation of IgA1 in DAKIKI cells. Biochem Biophys Res Commun. 2014;444:276–281.
14. W.Qin, Q.Zhou, L.C.Yang,. Peripheral B lymphocyte beta1,3-galactosyltransferase and chaperone expression in immunoglobulin A nephropathy. J Intern Med. 2005;258:467–477.
15. G.Serino, F.Sallustio, S.N.Cox, F.Pesce, F.P.Schena. Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy. J Am Soc Nephrol. 2012;23:814–824.
16. W.D.Chey, B.C.Wong, Practice Parameters Committee of the American College of Gastroenterology. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007;102:1808–1825.
17. A.M.Somily, M.Morshed An update of laboratory diagnosis of Helicobacter pylori in the Kingdom of Saudi Arabia. J Infect Dev Ctries. 2015;9:806–814.
18. G.H.Ko, H.B.Park, M.K.Shin,. Monoclonal antibodies against Helicobacter pylori cross-react with human tissue. Helicobacter. 1997;2:210–215.
19. A.C.Smith, K.Molyneux, J.Feehally, J.Barratt O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy. J Am Soc Nephrol. 2006;17:3520–3528.
20. L.Pacifico, J.Fosbom, V.Tromba,. Helicobacter pylori infection and extragastric disorders in children:A critical update. World J Gastroenterol. 2014;20:1379–1401.
21. J.Xie, K.Kiryluk, W.Wang,. Predicting progression of IgA nephropathy:New clinical progression risk score. PLoS One. 2012;7:e38904. doi:10.1371/journal.pone.0038904.
22. W.Le, S.Liang, Y.Hu,. Long-term renal survival and related risk factors in patients with IgA nephropathy:Results from a cohort of 1155 cases in a Chinese adult population. Nephrol Dial Transplant. 2012;27:1479–1485.
23. T.Moriyama, K.Tanaka, C.Iwasaki,. Prognosis in IgA nephropathy:30-year analysis of 1,012 patients at a single center in Japan. PLoS One. 2014;9:e91756. doi:10.1371/journal.pone.0091756.
24. M.Goto, K.Wakai, T.Kawamura,. A scoring system to predict renal outcome in IgA nephropathy:A nationwide 10-year prospective cohort study. Nephrol Dial Transplant. 2009;24:3068–3074.